496 related articles for article (PubMed ID: 12174707)
1. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma.
Bjermer L; Diamant Z
Monaldi Arch Chest Dis; 2002 Feb; 57(1):76-83. PubMed ID: 12174707
[TBL] [Abstract][Full Text] [Related]
2. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
Chauhan BF; Ducharme FM
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003137. PubMed ID: 24459050
[TBL] [Abstract][Full Text] [Related]
3. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
[TBL] [Abstract][Full Text] [Related]
4. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
5. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ram FS; Cates CJ; Ducharme FM
Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
[TBL] [Abstract][Full Text] [Related]
6. Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: a population-based study.
Sadatsafavi M; Lynd L; Marra C; Bedouch P; Fitzgerald M
J Allergy Clin Immunol; 2013 Jul; 132(1):63-9. PubMed ID: 23545274
[TBL] [Abstract][Full Text] [Related]
7. Observational study of the additive effects of pranlukast on inflammatory markers of clinically stable asthma with inhaled corticosteroids and long-acting beta 2 agonists.
Tomari S; Matsuse H; Hirose H; Tsuchida T; Fukahori S; Fukushima C; Kawano T; Matsuo N; Kohno S
Respiration; 2008; 76(4):398-402. PubMed ID: 18689991
[TBL] [Abstract][Full Text] [Related]
8. Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma.
Rabinovitch N; Mauger DT; Reisdorph N; Covar R; Malka J; Lemanske RF; Morgan WJ; Guilbert TW; Zeiger RS; Bacharier LB; Szefler SJ
J Allergy Clin Immunol; 2014 Feb; 133(2):350-6. PubMed ID: 24084071
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene Receptor Antagonists and Antiallergy Drugs.
Tamada T; Ichinose M
Handb Exp Pharmacol; 2017; 237():153-169. PubMed ID: 27826703
[TBL] [Abstract][Full Text] [Related]
10. Comparison of leukotriene receptor antagonists in addition to inhaled corticosteroid and inhaled corticosteroid alone in the treatment of adolescents and adults with bronchial asthma: a meta-analysis.
Cao Y; Wang J; Bunjhoo H; Xie M; Xu Y; Fang H
Asian Pac J Allergy Immunol; 2012 Jun; 30(2):130-8. PubMed ID: 22830292
[TBL] [Abstract][Full Text] [Related]
11. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
12. Long-acting beta2-agonists or leukotriene receptor antagonists as add-on therapy to inhaled corticosteroids for the treatment of persistent asthma.
Ringdal N
Drugs; 2003; 63 Suppl 2():21-33. PubMed ID: 14984078
[TBL] [Abstract][Full Text] [Related]
13. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
Fal AM; Kopeć A
Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
[TBL] [Abstract][Full Text] [Related]
14. Regulation of leukotrienes in the management of asthma: biology and clinical therapy.
Leff AR
Annu Rev Med; 2001; 52():1-14. PubMed ID: 11160764
[TBL] [Abstract][Full Text] [Related]
15. Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids.
Wu AC; Li L; Fung V; Kharbanda EO; Larkin EK; Vollmer WM; Butler MG; Miroshnik I; Rusinak D; Davis RL; Hartert T; Weiss ST; Lieu TA
J Allergy Clin Immunol Pract; 2014; 2(5):607-13. PubMed ID: 25213056
[TBL] [Abstract][Full Text] [Related]
16. Addition of leukotriene receptor antagonists to inhaled corticosteroids improved QOL of patients with bronchial asthma surveyed in suburban Tokyo, Japan.
Ohshima N; Matsui H; Matsui Y; Kawashima M; Shimada M; Higaki N; Shoji S; Wada H; Fujita A; Watanabe H; Yamaguchi N; Matsuoka R; Oki K; Takahashi H; Suzuki M; Yamazaki H; Yoshizawa M; Goto H
Allergol Int; 2011 Dec; 60(4):473-81. PubMed ID: 21681017
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene modifiers in pediatric asthma management.
Bisgaard H
Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study.
Murray CS; Thomas M; Richardson K; Price DB; Turner SW
J Allergy Clin Immunol Pract; 2017; 5(4):1082-1090.e7. PubMed ID: 28351789
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
Bisgaard H
Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
